🔧 Collaborating for automated cell line development: combining ExcellGene’s high-yield mammalian CHOExpress®️ system, together with CYTENA’s C.STATION™️ next generation automated workstation, allows for unprecedented breakthroughs in cell line workflows, resulting in high-producing cell lines that generate biotherapeutic proteins ‘faster, safer, and more affordably.’ The key feature of this collaboration is achieving monoclonality more efficiently, enabling a fully automated, contamination-free, cell-based protein manufacturing process that is agile and robust for producing mAbs and other complex therapeutic proteins. This next generation technology will revolutionize the production of therapeutic proteins by reducing costly delays in identifying monoclonal cell lines, and by eradicating nuisance contamination. #Monoclonality #Celllinedevelopment #biotherapeutics #automation #biotechnology